Case ID: 4183     Solution ID: 30399

Metabical Pricing Packaging and Demand Forecasting Recommendations for a New Weight Loss Drug Brief Case Case Solution


At the point when understudies have the English-language PDF of this Brief Case in a coursepack, they will likewise have the choice to buy a audio version. Metabical is another weight reduction sedate from Cambridge Sciences Pharmaceuticals expected for decently overweight people. In expectation of conclusive FDA endorsement, the senior executive of promoting, Barbara Printup, gets ready for the item dispatch and should settle on a few basic choices. To start with, she should choose the ideal bundling size for the medication which normally requires a 12-week course of treatment. Next, she should decide the fitting valuing. Since most insurance agencies don't cover weight reduction medicines, cost directly affects the business gauge. To set up the underlying interest gauge, Printup considers three methodologies in light of various suppositions. Her last suggestions must consider long haul gainfulness and meet the organization's craved profit for investment.The case incorporates a quantitative task for understudies.

Request Case Study Solution

Prepared by MBAs and CFAs according to your requirements



Already Registered? Login here!


Order Summary

SubjectNot Selected
LengthNot Selected
Deadline Not Selected
Estimated Submission On
Total 0